Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
GUFICBIO
₹386.10
₹382.10
₹399.00
₹268.00
₹448.00
Markets Today
Historical Performance
As of 22-07-2026 22:50, Gufic BioSciences Ltd. share price today is ₹0, with a change of ₹-396.70 (-100.00%) from the previous close of ₹396.7. The stock opened at ₹399 and traded between ₹382.1 and ₹399, with a total traded volume of 51542 shares. The company has a market capitalization of ₹3978.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹448 and ₹268, respectively.
Gufic BioSciences Ltd. valuation metrics include a P/E ratio of 62, EPS of ₹6.4, and book value of ₹6.00. Profitability indicators show ROE of 9.65%. Gufic BioSciences Ltd. has reported revenue of ₹944.01 Cr and net profit of ₹64.21 Cr.
Gufic BioSciences Ltd. technical indicators include Day RSI at 59.15, Day MFI at 63.99, Day ADX at 41.73. Additional indicators include Commodity Channel Index (CCI) at 44.1 and Williams %R at -29.22. Momentum indicators show Day MACD at 10.19, Day MACD Signal Line at 11.75, DayATR at 17. Rate of Change indicators for Gufic BioSciences Ltd. include ROC125 at 25.92 and ROC21 at 11.67.
Exponential moving averages include EMA5 at ₹392.6, EMA10 at ₹390.7, EMA12 at ₹389.7, EMA20 at ₹384.3, EMA26 at ₹379.5, EMA50 at ₹361.4, EMA100 at ₹342.4, EMA200 at ₹337.6. Simple moving averages include SMA5 at ₹391.4, SMA10 at ₹391.6, SMA20 at ₹386.8, SMA30 at ₹379.4, SMA50 at ₹354.5, SMA100 at ₹322.2, SMA150 at ₹322, SMA200 at ₹327.9.
Support levels for Gufic BioSciences are placed at First Support ₹388.87, Second Support ₹381.03, Third Support ₹375.97. Resistance levels are seen at First Resistance ₹401.77, Second Resistance ₹406.83, Third Resistance ₹414.67. Gufic BioSciences Ltd. shareholding pattern shows promoter holding at 72.5%, FII holding at 0.47%, DII holding at 0%, public holding at 23.36%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 252.05 | 231.09 | 230.42 | 226.91 | 205.02 |
| Operating Expense | 206.14 | 194.79 | 194.62 | 194.58 | 178.38 |
| Operating Profit | 45.91 | 36.31 | 35.80 | 32.34 | 26.64 |
| Depreciation | 7.65 | 7.69 | 7.77 | 7.72 | 7.84 |
| Interest | 9.44 | 8.36 | 9.58 | 9.23 | 8.40 |
| Tax | 7.05 | 5.49 | 5.59 | 4.20 | 2.81 |
| Net Profit | 20.57 | 15.56 | 14.94 | 12.07 | 7.97 |
₹386.10
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 72.5 | 72.5 | 72.5 | 72.5 | 72.5 | 72.5 |
| FII | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 |
| DII | 3.4 | 3.4 | 3.7 | 3.8 | 3.8 | 3.6 |
| Public | 23.8 | 23.8 | 23.5 | 23.3 | 23.2 | 23.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 59.17 K | 93.04 K | 63.60% |
| Week | 41.53 K | 78.43 K | 52.96% |
| 1 Month | 1.11 L | 5.71 L | 19.51% |
| 6 Month | 54.1 K | 1.69 L | 32.09% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 22 Sep, 2025 | 0.1 | FINAL | 22 Sep, 2025 | Equity Share |
| 18 Sep, 2024 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2023 | 0.1 | FINAL | Equity Share | |
| 24 Aug, 2022 | 0.1 | FINAL | Equity Share | |
| 09 Sep, 2021 | 0.1 | FINAL | Equity Share | |
| 03 Nov, 2020 | 0.05 | FINAL | Equity Share | |
| 20 Sep, 2019 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2018 | 0.05 | FINAL | Equity Share | |
| 28 Aug, 2017 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2016 | 0.05 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹548.70 | ₹5.19 | ₹167 | ₹14.92 | ₹53.29 | ₹64.40 |
| % Change | -1.90% | 1.17% | -0.55% | -2.93% | -6.21% | -2.32% |
| Revenue TTM (₹ Cr) | - | ₹69.99 | ₹287.68 | ₹176.50 | ₹1,805.69 | ₹128.44 |
| Net Profit TTM (₹ Cr) | - | ₹-176.47 | ₹14.88 | ₹27.81 | ₹94.88 | ₹-10.03 |
| PE TTM | - | -0.20 | 43.80 | 29.40 | 32.80 | -23.50 |
| 1 Year Return | 42.69 | 413 | 33.28 | 68.9 | -8.28 | -42.17 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 7.64 | -7.00 |
Amrutanjan Health Care Ltd.
₹ 527.35
-2.09%
Valiant Laboratories Ltd.
₹ 62.79
-0.17%
Sigachi Industries Ltd.
₹ 26.55
+2.00%
Windlas Biotech Ltd.
₹ 870.00
-1.19%
Vineet Laboratories Ltd.
₹ 37.05
-2.55%
Solara Active Pharma Sciences Ltd.
₹ 537.00
-3.90%
Zim Laboratories Ltd.
₹ 116.52
-1.74%
Medico Remedies Ltd.
₹ 38.40
-0.57%
Dishman Carbogen Amcis Ltd.
₹ 185.10
-2.68%
Lasa Supergenerics Ltd.
₹ 7.06
-3.29%
Advanced Enzyme Technologies Ltd.
₹ 313.00
-2.60%
Bajaj Healthcare Ltd.
₹ 321.90
-12.85%
Ortin Global Ltd.
₹ 14.98
+0.07%
Brooks Laboratories Ltd.
₹ 67.09
+1.10%
RPG Life Sciences Ltd.
₹ 2985.00
-0.43%
Bafna Pharmaceuticals Ltd.
₹ 238.25
+2.00%
Alpa Laboratories Ltd.
₹ 66.25
-2.05%
SMS Pharmaceuticals Ltd.
₹ 386.00
-0.57%
Nectar Lifesciences Ltd.
₹ 10.55
-1.40%
Mangalam Drugs and Organics Ltd.
₹ 27.27
+0.04%
Indoco Remedies Ltd.
₹ 232.66
-5.36%
Ind-Swift Laboratories Ltd.
₹ 232.98
-1.94%
Lincoln Pharmaceuticals Ltd.
₹ 577.00
-3.59%
Panacea Biotec Ltd.
₹ 462.00
-6.48%
By signing up I certify terms, conditions & privacy policy